What is Seaport Therapeutics 's accrued liabilities & other?

Seaport Therapeutics (SPTX) reported accrued liabilities & other of $7.83M in Q1 2026.

What does accrued liabilities & other mean?

Combined accrued expenses and miscellaneous current liabilities not classified in specific categories.

Seaport Therapeutics SPTX Accrued Liabilities & Other

Accrued Liabilities & Other at other companies

PegasystemsPEGA

$6.78M+42.1%

Navitas Semiconductor CorporationNVTS

$18.44M+29.2%

Avis Budget GroupCAR

$649M+44.5%

Navan, Inc. NAVN

$185.3M—

Evolution Metals & Technologies Corp. EMAT

$800K—

SPT

Seaport Therapeutics SPTX

$7.83M—

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's accrued liabilities & other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's accrued liabilities & other?: Seaport Therapeutics (SPTX) reported accrued liabilities & other of $7.83M in Q1 2026.
What does accrued liabilities & other mean?: Combined accrued expenses and miscellaneous current liabilities not classified in specific categories.